Potential therapeutic and pharmacological strategies for SARS-CoV2

被引:0
作者
Doaa A. Ghareeb
Samar R. Saleh
Mohammed S. Nofal
Mohamed M. Y. Kaddah
Salma. F. Hassan
Inas K. Seif
Sally A. El-Zahaby
Shaimaa M. Khedr
Marwa Y. Kenawy
Aliaa A. Masoud
Salma A. Soudi
Ahmed A. Sobhy
Jaillan G. Sery
Miral G. Abd El-Wahab
Alshimaa A. Abd Elmoneam
Abdulaziz Mohsen Al-mahallawi
Maha A. El-Demellawy
机构
[1] Alexandria University,Biological Screening and Preclinical Trial Laboratory, Department of Biochemistry, Faculty of Science
[2] City of Scientific Research and Technological Applications (SRTA-City),Pharmaceutical and Fermentation Industries Development Centre (PFIDC)
[3] Pharos University in Alexandria,Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy
[4] City of Scientific Research and Technological Applications (SRTA-City),Fabrication Technology Department, Advanced Technology and New Materials Research Institute (ATNMRI)
[5] Alexandria University,Clinical Pharmacy Program, Faculty of Pharmacy
[6] Cairo University,Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy
[7] October University for Modern Sciences and Arts (MSA),Department of Pharmaceutics, Faculty of Pharmacy
[8] GEBRI,Medical Biotechnology Department
[9] SRTA-City,undefined
来源
Journal of Pharmaceutical Investigation | 2021年 / 51卷
关键词
COVID-19; Hydroxychloroquine; Indomethacin; Tocilizumab; Teicoplanin; Camostat;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:281 / 296
页数:15
相关论文
共 707 条
[1]  
Amarelle L(2017)Anti-influenza treatment: drugs currently used and under development Arch Bronconeumol 53 19-26
[2]  
Lecuona E(2006)Indomethacin has a potent antiviral activity against SARS coronavirus Antivir Ther 11 1021-1030
[3]  
Sznajder JI(2001)Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial Antiviral Res 49 75-81
[4]  
Amici C(2006)Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics Antiviral Res 72 20-33
[5]  
di Caro A(2003)Antiretroviral activity of semisynthetic derivatives of glycopeptide antibiotics J Med Chem 46 2755-2764
[6]  
Ciucci A(2020)Teicoplanin: an alternative drug for the treatment of COVID-19? Int J Antimicrob Agents 55 105944-105944
[7]  
Chiappa L(2008)Lopinavir/ritonavir in the treatment of HIV-1 infection: a review Ther Clin Risk Manag 4 1023-1033
[8]  
Castilletti C(2020)Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet 395 507-513
[9]  
Martella V(2020)Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro Antiviral Res 178 104786-352
[10]  
Decaro N(2016)Fighting viruses with antibiotics: an overlooked path Int J Antimicrob Agents 48 349-2635